| Dr Lawrence Wayne Davidow, PHD, RPH | |
|
2010 Becker Dr, Lawrence, KS 66047-1620 | |
| (785) 864-4527 | |
| (785) 864-5562 |
| Full Name | Dr Lawrence Wayne Davidow |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2010 Becker Dr, Lawrence, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730694761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11465 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lawrence Wayne Davidow, PHD, RPH 2010 Becker Dr, Lawrence, KS 66047-1620 Ph: (785) 864-4527 | Dr Lawrence Wayne Davidow, PHD, RPH 2010 Becker Dr, Lawrence, KS 66047-1620 Ph: (785) 864-4527 |
News Archive
Delphi Medical Systems Corporation, a subsidiary of Delphi Corporation, recently signed a licensing agreement with Switzerland-based medical device company Debiotech, S.A.
Nissay Information Technology and IBM Japan today announced they will jointly build a cloud-based development and test environment to create mission critical Web systems for Nippon Life Insurance (NISSAY). The project launched in May 2010, with the test and development environment expected to go live in September 2010.
Patients with atrial fibrillation (AF), a rapid irregular heartbeat caused by pooling blood in the heart which can lead to heart failure and stroke, are often treated with an ablation, a minimally invasive procedure used to remove the tissue which causes the pooled blood.
Relypsa, Inc., a biopharmaceutical company developing non-absorbed polymeric drugs, today announced positive results from the company's PEARL-HF study, a Phase 2 clinical trial of the company's lead compound, RLY5016. These data were presented by Dr. Bertram Pitt, Professor of Medicine Emeritus, Division of Medicine at the University of Michigan School of Medicine, during the Late-Breaking Clinical Trials Session in an oral presentation titled "The PEARL-HF (Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multiple-Dose To Evaluate the Effects of RLY5016 in Heart Failure Patients) Trial" at the 14th Annual Scientific Meeting of the Heart Failure Society of America held in San Diego, CA September 13-15, 2010.
› Verified 7 days ago
Jakob Ready, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3421 W 6th St, Lawrence, KS 66049 Phone: 785-841-9000 | |
Carrie Lynn Williams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2336 Ridge Ct, Ste C, Lawrence, KS 66046 Phone: 785-841-1950 Fax: 785-841-1051 | |
William J Anderson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1410 Kasold Dr, Ste A16, Lawrence, KS 66049 Phone: 785-843-8555 Fax: 785-843-0645 | |
Nikita Gandhi, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2300 Iowa St, Lawrence, KS 66046 Phone: 785-832-1112 | |
Dr. Michelle Wessling, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 325 Maine St, Lawrence, KS 66044 Phone: 785-505-5127 | |
Bridget Ellen Gillespie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 400 W 23rd Street, Lawrence, KS 66046 Phone: 785-832-8388 | |
Lauren Dick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1016 Lakecrest Rd, Lawrence, KS 66049 Phone: 785-218-9287 |